David Steensma, MD (@davidsteensma) 's Twitter Profile
David Steensma, MD

@davidsteensma

Hematologist-oncologist. @AjaxThx CMO. Former Edward P. Evans Chair in MDS @DanaFarber, @HarvardMed & @MayoClinic faculty, @NovartisScience hematology head.

ID: 2739065578

calendar_today10-08-2014 14:36:07

7,7K Tweet

25,25K Followers

460 Following

David Steensma, MD (@davidsteensma) 's Twitter Profile Photo
David Steensma, MD
@davidsteensma

2 months ago

So far, every single abstract I’ve listened to at #EHA25 reporting a clinical trial has claimed the study drug was “well tolerated” - despite patients discontinuing therapy due to AEs. One speaker said “well tolerated” >10 times. It’s meaningless. Let data speak for itself.